Boulder, Colorado -– BiOptix is pleased to announce the appointment of Ken Dickerson as Vice President of Sales. Ken joins the company from ACEA Biosciences where he was National Sales Director. Ken has also held sales management positions at Roche and GE Healthcare over his 20 year career. “I am excited to have Ken join […]
The omniDOC series of gel documentation and analysis systems from Cleaver Scientific provide researchers with a quick, simple and flexible solution for their gel documentation needs in a compact and affordable benchtop unit. Uniquely combining high performance, leading edge features and affordability the omniDOC series provide an easy-to-use, yet powerful gel imaging system that satisfies […]
SGS Life Science Services, the leading pharmaceutical clinical and bioanalytical contract solutions provider, today announced that its laboratory in Poitiers, France, has successfully completed a full analytical validation of the novel Meso Scale Discovery (MSD®) V-PLEX 10-plex Proinflammatory Panel I, for use with human plasma samples. The validation included measurement of accuracy, recovery, dilutional linearity, […]
CARLSBAD, Calif. — Thermo Fisher Scientific today announced it has signed an agreement with Cynvenio Biosystems Inc., a molecular testing company focused on the genomic analysis of tumor biomarkers in the bloodstream, for rights to distribute its LiquidBiopsy platform. The addition of Cynvenio’s rare cell enrichment technology complements Thermo Fisher’s Ion Torrent Personal Genome Machine […]
SOUTH SAN FRANCISCO, Calif. –– Fluidigm Corporation (NASDAQ:FLDM) today announced total revenue for the fourth quarter of 2014 is expected to be approximately $33.4 million based on preliminary, unaudited financial data. Organic revenue for the fourth quarter of 2014 (excluding revenue attributable to the DVS Sciences acquisition, comprised of the CyTOF® 2 system and proteomics […]
Fluidic Analytics has developed a proprietary technology to characterise proteins in a rapid, accurate and cost-effective manner. The technology is based on research conducted at the University of Cambridge and has high-value applications including identifying markers that indicate the onset of diseases in the human body. In contrast to DNA, whose sequence provides information on […]
SEATTLE — NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided an update on operational and preliminary financial results for the year ended December 31, 2014. Financial Highlights include: Total revenue for 2014 is expected to be in the range of $47.0 to $48.0 million, […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced a new single-cell application for its C1TM system that improves whole genome sequencing of individual cells. Single-cell whole genome sequencing allows researchers to explore mutations in regulatory and protein coding regions of the genome in order to identify novel signatures within heterogeneous cell populations. This […]
SOUTH SAN FRANCISCO, Calif., HINXTON, U.K. — A formal collaboration was announced today between the Wellcome Trust Sanger Institute, the European Bioinformatics Institute (EMBL-EBI) and Fluidigm Corporation (NASDAQ:FLDM) to accelerate the development of new methods for the analysis of single-cell genomics data. The Single Cell Genomics Centre (SCGC) on the Wellcome Trust Genome Campus will […]
Lexington, Mass — Quanterix, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced the opening of The Simoa Accelerator, a dedicated laboratory environment for custom assay development and clinical sample testing. Designed to provide access to the revolutionary Single Molecule Array (Simoa) HD-1 Analyzer, this […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
